Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma

Conclusion: Survival outcomes, pelvic tumor control, and Grade III and IV complications were not significantly different in the LDR brachytherapy group compared with the HDR group.